AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group’s CEO will testify on Capitol Hill.
But AbbVie has two key drugs that treat many of the same conditions as Humira, and they are proving to be worthy successors to the company's flagship medication.
But AbbVie is still"successfully navigating" Humira's patent cliff, the company's CEO Rick Gonzalez said on an earnings call last week. Those newer drugs are growing rapidly: Skyrizi's sales jumped 48% from the same period a year ago, while Rinvoq revenue spiked 59%. Meanwhile, Rinvoq is seeing uptake rise among patients with inflammatory bowel disease, ulcerative colitis and Crohn's disease, among other indications.
Change Healthcare offers tools for payment and revenue cycle management, among other solutions like e-prescription software. It carries out 15 billion billing transactions annually, and one in three patient records pass through its systems, according to the company.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successorsAbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group’s CEO will testify on Capitol Hill.
Read more »
Drugmaker AbbVie expects Humira volume erosion to worsenDrugmaker AbbVie expects Humira volume erosion to worsen
Read more »
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billionDrugmakers spent big on ads for weight loss and diabetes drugs such as Wegovy and Ozempic. Meanwhile, the FDA approved the first AI diagnostic tool for sepsis.
Read more »
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rivalJ&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s…
Read more »
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medicationsU.S. medication shortages are at a record high so far this year. Meanwhile, UnitedHealth revealed the financial impact of the Change Healthcare cyberattack.
Read more »
Boehringer to lay off salespeople as Humira biosimilar sales lagBoehringer to lay off salespeople as Humira biosimilar sales lag
Read more »